Other studies demonstrated that Wnt5a could enhance migration of breast-cancer cells.13,14 In this study, we found that Wnt5a enhances the migration of serum-starved breast-cancer PDX cells that expressed ROR1, and that such effects could also be blocked by cirmtuzumab (Fig. 2g). This evidence concerns the gene WNT5A and breast carcinoma.